142 related articles for article (PubMed ID: 12006958)
1. Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis.
Eubanks V; Koppersmith N; Wooldridge N; Clancy JP; Lyrene R; Arani RB; Lee J; Moldawer L; Atchison J; Sorscher EJ; Makris CM
J Pediatr; 2002 Apr; 140(4):439-44. PubMed ID: 12006958
[TBL] [Abstract][Full Text] [Related]
2. Achieving genetic potential for nutrition and growth in cystic fibrosis.
Shepherd R
J Pediatr; 2002 Apr; 140(4):393-5. PubMed ID: 12006951
[No Abstract] [Full Text] [Related]
3. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis.
Marchand V; Baker SS; Stark TJ; Baker RD
J Pediatr Gastroenterol Nutr; 2000 Sep; 31(3):264-9. PubMed ID: 10997370
[TBL] [Abstract][Full Text] [Related]
5. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
[TBL] [Abstract][Full Text] [Related]
6. Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease.
Efrati O; Mei-Zahav M; Rivlin J; Kerem E; Blau H; Barak A; Bujanover Y; Augarten A; Cochavi B; Yahav Y; Modan-Moses D
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):222-8. PubMed ID: 16456419
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
[TBL] [Abstract][Full Text] [Related]
8. Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis.
Homnick DN; Marks JH; Hare KL; Bonnema SK
Pediatr Pulmonol; 2005 Sep; 40(3):251-6. PubMed ID: 16015665
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
Zemel BS; Jawad AF; FitzSimmons S; Stallings VA
J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
[TBL] [Abstract][Full Text] [Related]
10. Effect of high-dose ibuprofen in patients with cystic fibrosis.
Konstan MW; Byard PJ; Hoppel CL; Davis PB
N Engl J Med; 1995 Mar; 332(13):848-54. PubMed ID: 7503838
[TBL] [Abstract][Full Text] [Related]
11. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
Cruz JM; Muss HB; Brockschmidt JK; Evans GW
Semin Oncol; 1990 Dec; 17(6 Suppl 9):63-7. PubMed ID: 2259928
[TBL] [Abstract][Full Text] [Related]
12. [Supportive treatment with megestrol acetate during radio(chemo)therapy in patients with tumors in the head-neck area. A randomized study].
Fietkau R; Riepl M; Kettner H; Hinke A; Sauer R
Strahlenther Onkol; 1996 Mar; 172(3):162-8. PubMed ID: 8721265
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
[TBL] [Abstract][Full Text] [Related]
15. Reduced gains in fat and fat-free mass, and elevated leptin levels in children and adolescents with cystic fibrosis.
Ahme ML; Ong KK; Thomson AH; Dunger DB
Acta Paediatr; 2004 Sep; 93(9):1185-91. PubMed ID: 15384881
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
Hordvik NL; Sammut PH; Judy CG; Colombo JL
Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
[TBL] [Abstract][Full Text] [Related]
17. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
Pirzada OM; McGaw J; Taylor CJ; Everard ML
J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
[TBL] [Abstract][Full Text] [Related]
18. Adrenal insufficiency and testicular failure secondary to megestrol acetate therapy in a patient with cystic fibrosis.
McKone EF; Tonelli MR; Aitken ML
Pediatr Pulmonol; 2002 Nov; 34(5):381-3. PubMed ID: 12357484
[TBL] [Abstract][Full Text] [Related]
19. Association of body composition and lung function in children with cystic fibrosis.
Pedreira CC; Robert RG; Dalton V; Oliver MR; Carlin JB; Robinson P; Cameron FJ
Pediatr Pulmonol; 2005 Mar; 39(3):276-80. PubMed ID: 15668934
[TBL] [Abstract][Full Text] [Related]
20. Cyproheptadine is an effective appetite stimulant in cystic fibrosis.
Homnick DN; Homnick BD; Reeves AJ; Marks JH; Pimentel RS; Bonnema SK
Pediatr Pulmonol; 2004 Aug; 38(2):129-34. PubMed ID: 15211696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
